Thanks vetschoice, I wasn’t aware of that sunset clause.
Digging a bit more, I note that it has been proposed to extend the rare paediatric disease priority review voucher system for another three years (and also to apply it only to serious diseases) as part of the 21st Century Cures legislation (Sec. 2152).
That bill passed through the House of Representatives last month with high levels of bipartisan support and is now before the Senate. Voting on the bill is expected to take place either later this year or early next year.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)